US2006183163A1PendingUtilityA1
Methods and compositions for screening for modulators of IgE synthesis, secretion and switch rearrangement
Est. expiryMay 12, 2018(expired)· nominal 20-yr term from priority
C12Q 1/6897G01N 2500/10G01N 33/5023C07K 14/70578C07K 2319/00C12N 15/63C12N 15/1079G01N 33/5008C12N 2510/00G01N 33/5047
64
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to methods and compositions useful in screening for modulators of IgE synthesis, secretion and switch rearrangement.
Claims
exact text as granted — not AI-modified1 - 28 . (canceled)
29 . A cultured mammalian cell comprising:
a nuclear genome comprising a recombinant nucleic acid comprising:
a) an IL-4 inducible fragment of an IgG epsilon promoter; and
b) a polynucleotide encoding a reporter protein;
wherein said IL-4 inducible fragment of said IgG epsilon promoter and said polynucleotide encoding said reporter protein are operably linked such that expression of said reporter protein is IL-4 inducible.
30 . The cultured mammalian cell of claim 29 , wherein said cultured mammalian cell is an IgM + B cell.
31 . The cultured mammalian cell of claim 29 , wherein said reporter protein is an optically detectable protein, a death protein, or a survival protein.
32 . The cultured mammalian cell of claim 29 , wherein said reporter protein is an optically detectable protein.
33 . The cultured mammalian cell of claim 29 , wherein said reporter protein is a fusion protein.
34 . The cultured mammalian cell of claim 33 , wherein said fusion protein comprises two reporter domains.
35 . The cultured mammalian cell of claim 33 , wherein said fusion protein comprises an IgE heavy chain domain and reporter domain.
36 . The cultured mammalian cell of claim 33 , wherein said IgG epsilon promoter is endogenous to said nuclear genome.
37 . The cultured mammalian cell of claim 33 , wherein said IgG epsilon promoter is exogenous to said nuclear genome.
38 . The cultured mammalian cell of claim 29 , further comprising nucleic acid encoding a test peptide.
39 . The cultured mammalian cell of claim 29 , wherein said peptide comprises a random sequence of amino acids.
40 . A method of using the cultured mammalian cell of claim 29 , comprising:
contacting said cultured mammalian cell with a test agent; and detecting an effect of said test agent on IL-4 inducible expression of said reporter protein.
41 . The method of claim 40 , wherein said agent is an organic molecule having a molecular weight of less than 2500 Da.
42 . The method of claim 40 , wherein said contacting comprises introducing said test agent into said cell.
43 . The method of claim 40 , wherein said agent is a polypeptide or polynucleotide page 19, lines 23-25
44 . The method of claim 40 , wherein said nucleic acid encodes a random peptide.
45 . A method of making the cultured mammalian cell of claim 29 , comprising:
introducing into a cell a vector comprising a recombinant nucleic acid comprising:
a) an IL-4 inducible fragment of an IgG epsilon promoter; and
b) a polynucleotide encoding a reporter protein; and
culturing said cell under conditions for selection for cells in which said recombinant nucleic acid has integrated into said genome.
46 . The method of claim 45 , further comprising selecting a cell that does not detectably produce said reporter protein in the absence of IL-4.
47 . The method of claim 45 , wherein said vector is a retroviral vector.Join the waitlist — get patent alerts
Track US2006183163A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.